SOD1 and infection: Ferrostatin-1 treatment also significantly reduced the Fe2+ (>2-fold) concentration in hepatocytes (Figure 4E), decreased intracellular ROS (Figure 4G(a,b)), and restored intracellular GSH (>2-fold) (Figure 4F) and SOD (Figure 4H) concentration from PSCs infection.